DIRS.INFO The most relevant business & tech news

☆ Kansas City Stars, With Help From Taylor Swift, Are Advertising Champs
▼ + stars: | 2024-02-08 | by ( Santul Nerkar | ) www.nytimes.com time to read: +1 min

The Kansas City Chiefs enter Sunday’s Super Bowl having already won — when it comes to commercials. Over the past year, the star players Patrick Mahomes and Travis Kelce, along with Coach Andy Reid, have been inescapable to TV viewers. The estimated amount spent to air the ads on television was $178 million for Mr. Mahomes, $120 million for Mr. Kelce and $69 million for Mr. Reid, according to iSpot.tv, an ad measurement company. Because there were several commercials in which at least two of the three appeared, the dollar totals have some overlap. Basically, the more spend an ad has, the more viewers are seeing it.

Persons: Patrick Mahomes, Travis Kelce, Andy Reid, Kelce baring, Mahomes, Reid, Kelce, ”, Cassandra Arora, Deion Sanders, Nick Saban, Christian McCaffrey, Brock Purdy Organizations: Kansas City Chiefs, Sunday’s, Pfizer, National Football League, “ Brands, Chiefs, University of Colorado’s, University of Alabama, 49ers, Toyota Locations: San Francisco

☆ Opinion | Taylor Swift and the Profound Weirdness of MAGA
▼ + stars: | 2024-02-04 | by ( David French | ) www.nytimes.com time to read: +2 min

That’s a key lesson of the MAGA right’s deeply strange turn against Taylor Swift and her boyfriend, the Kansas City Chiefs’ star tight end Travis Kelce. In fact, that’s a key lesson from this entire sorry era in American political and cultural life. Even as he condemned Swift, one prominent MAGA figure recently boasted that his “side” still had Kid Rock, Ted Nugent and Jon Voight. According to them, Taylor Swift’s extraordinary popularity isn’t the organic outcome of a talented and appealing superstar’s bond with her fans. No, according to them, Swift’s rise is an “op” or a “psyop” engineered by the deep state in order to benefit Joe Biden.

Persons: Hatred, MAGA, Taylor Swift, Travis Kelce, Swift, Phil Bredesen, Republican Marsha Blackburn, Joe Biden, Kelce, “, Laura Ingraham’s, Rock, Ted Nugent, Jon Voight, Ronald Reagan, Donald Trump, can’t, Taylor Organizations: Kansas City Chiefs, Democratic, Senate, Republican, Pfizer, —, Fox News, Dixie Locations: Tennessee, MAGA America

☆ Nobel Prize winner Katalin Karikó was 'demoted 4 times' at her old job. How she persisted: 'You have to focus on what's next'
▼ + stars: | 2023-10-06 | by ( Aditi Shrikant | ) www.cnbc.com time to read: +6 min

On Monday, Karikó, along with her collaborator Drew Weissman, won the Nobel Prize in Physiology and Medicine. It's clear, and impressive, that Karikó didn't take those obstacles personally. Suhadolnik didn't receive the news well, she says. If you have a Ph.D. from an American Ivy League [university], that's better compared to if you have a degree from a foreign university." The type of work Karikó does, Feigl-Ding says, doesn't make splashy headlines, because groundbreaking work rarely does.

Persons: Pfizer Covid, Katalin, Drew Weissman, Karikó, didn't, Robert J, Suhadolnik, Susan, Suhadolnik didn't, Gregory Zuckerman's, I'm, wasn't, Eric Feigl, Ding, doesn't, Nobel, Albert Einstein didn't, Ding epidemiologist, Weissman Organizations: Pfizer, Moderna, CNBC, University of Pennsylvania, University of Szeged, Biological Research, Temple University, Uniformed Services University of, Health Sciences, New, Systems Institute, Harvard Medical School, American Ivy League, Universities, Systems, Harvard Medical Locations: Hungary, Philadelphia, Bethesda , Maryland, UPenn, United States, U.S, New England

☆ Why startups are investing millions to make drugs and semiconductors in space
▼ + stars: | 2023-08-20 | by ( Magdalena Petrova | ) www.cnbc.com time to read: +4 min

Now, several space startups see an opportunity to satisfy in-space manufacturing demand using compact space factories. One company is Varda Space Industries in Southern California. Varda Space Industries' first pharmaceutical manufacturing satellite and reentry vehicle attached to a Rocket Lab Photon bus. Years of research have shown that protein crystals grown in space are much higher quality than those grown on Earth. Across the Atlantic in Cardiff, Wales, Space Forge is working on designing its own in-space factory to manufacture next-generation semiconductors.

Persons: Ilan Rozenkopf, Joe Biden, Varda, Asparouhov, we've, Andrew Parlock Organizations: pharma, McKinsey . Space, NASA, ISS, Varda Space Industries, Pfizer, Space Locations: vacuumless, Southern California, U.S, Cardiff , Wales, Space Forge's

☆ New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
▼ + stars: | 2023-07-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Regardless of that shift, experts say vaccine uptake may not look much different from that of the bivalent boosters. Pandemic fatigue, confusionFatigue over the pandemic and the general belief that Covid is "over" could potentially hinder the uptake of new shots this fall, experts said. Ipsos and Axios released a survey with similar findings in May, the same month the U.S. ended the national Covid public health emergency amid a downward trend in cases, hospitalizations and deaths. "That contrasts with what we've seen in the past where there are different vaccines, different timing, different age groups and something new to consider every few months." Advisors to the FDA have raised concerns about shifting to yearly Covid vaccines, noting that it's unclear if the virus is seasonal like the flu.

Persons: Antonio Perez, Axios, isn't, Dr, Kartik Cherabuddi, Brad Pollock, Pollock, they're, Ashley McGee, Justin Sullivan, CDC hasn't, Covid, KFF's Kates, Michael Nagle, Kates, we've Organizations: Chicago CVS, Tribune, Service, Getty Images Pfizer, Moderna, Pfizer, Gallup, University of Florida, CNBC, UC Davis Health's, Safeway, CDC, Food and Drug Administration, Health, Human Services Department, FDA, Xinhua News Agency, Getty Locations: Chicago, U.S, San Rafael , California, New York, United States

☆ FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
▼ + stars: | 2023-05-25 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

The Food and Drug Administration on Thursday granted full approval to Pfizer's Covid antiviral pill, Paxlovid, for adults who are at high risk of getting severely sick with the virus. The FDA first made Paxlovid available in December 2021 under emergency use authorization for high-risk individuals ages 12 and up. Both Pfizer and the FDA view the treatment as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections and ultimately save lives. For some doctors, another area of concern is Paxlovid "rebound cases." That's when patients who take the treatment see their Covid symptoms return or test positive shortly after they initially recover.

☆ Fact Check-COVID ‘monovalent’ vaccines not banned, FDA approval not withdrawn
▼ + stars: | 2023-04-25 | by ( Reuters Fact Check | ) www.reuters.com time to read: +6 min

But the original vaccines remain licensed in the United States and are not “banned” as suggested by some social media users. An FDA spokesperson also commented on the agency’s official Twitter account: “It's probably worth clarifying that the monovalent vaccines are still approved (licensed). EUA information for the Moderna and Pfizer vaccines can be seen on the FDA website (here) , (here). The FDA withdrew authorizations for emergency use of Pfizer-BioNTech and Moderna monovalent COVID vaccines while authorizing use of the updated, bivalent versions in all age groups. The agency did not withdraw its approval or license of the original vaccines, nor “ban” their use.

☆ Fact Check-Document mentioning cryogenic-electron microscopy does not prove Pfizer COVID-19 vaccine contains graphene oxide
▼ + stars: | 2023-04-04 | by ( Reuters Fact Check | ) www.reuters.com time to read: +4 min

Graphene oxide is not an ingredient in the vaccine,” she said. When contacted by Reuters, a Pfizer spokesperson sent a link with the full list of ingredients of the Pfizer-BioNTech COVID-19 vaccine (here, see page six). No graphene oxide is listed. “We confirm that graphene oxide is not used in the manufacture of the Pfizer-BioNTech COVID-19 vaccine,” the spokesperson said. The Pfizer COVID-19 vaccine does not contain graphene oxide.

☆ Fact Check-Experts say Pfizer COVID vaccine trials did not cause more miscarriages and there is no evidence of COVID-19 vaccine impact on fertility
▼ + stars: | 2023-03-31 | by ( Reuters Fact Check | ) www.reuters.com time to read: +4 min

Women who got pregnant during Pfizer’s COVID vaccine trials did not have an unusual rate of miscarriage, experts said as they responded to an online video. This is a miscarriage rate of 14%, which is within the “normal” or expected rate of miscarriage per pregnancy, Male said. They also said there is no evidence of impact from COVID-19 vaccines on fertility. Pfizer started a global trial of pregnant women in February 2021. There is no evidence that COVID-19 vaccines affect fertility and pregnancies during Pfizer’s COVID vaccine trials did not have an unusual rate of miscarriage.

☆ FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
▼ + stars: | 2023-03-16 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

The Food and Drug Administration's independent panel of advisors recommended full approval of Pfizer's Covid-19 antiviral pill Paxlovid for high-risk adults 16-1 on Thursday, but flagged potentially harmful drug interactions. The FDA first made Paxlovid available in December 2021 for emergency use in high-risk individuals ages 12 and up. More than half of Paxlovid-eligible Medicare and Veterans Affairs patients are on medications that have drug interactions with Paxlovid, according to an FDA review of safety surveillance data. Roughly 74% of Paxlovid prescriptions were from adult primary care practitioners who may not be experienced with managing the possible adverse drug interactions, the FDA review added. To complete a full course of the drug, patients must take three Paxlovid pills twice a day for five days.

☆ FDA says Pfizer COVID pill EUA for adolescents to stay even after nod for adults
▼ + stars: | 2023-03-16 | by ( ) www.reuters.com time to read: +1 min

Companies Pfizer Inc FollowMarch 16 (Reuters) - The U.S. health regulator said on Thursday the current emergency use authorization (EUA) for Pfizer's COVID-19 antiviral pill for high-risk adolescents will continue to remain in effect even if it receives full approval for use in some adults. Paxlovid has been authorized for emergency use in mild-to-moderate COVID patients aged 12 years and older since late 2021, but Pfizer's application for full approval only covers high-risk adults. "Should this new drug application be approved, FDA anticipates that the EUA for Paxlovid will remain in effect to continue authorizing treatment of adolescents with mild-(to-)moderate COVID-19 and further address other access needs," the regulator added. A full approval would provide doctors more flexibility in prescribing the drug and also allow the company to expand its advertising campaign. Reporting by Leroy Leo and Khushi Mandowara in Bengaluru; Editing by Saumyadeb Chakrabarty and Krishna Chandra EluriOur Standards: The Thomson Reuters Trust Principles.

☆ EU silence over Pfizer COVID contract talks is problem that won't go away -watchdog
▼ + stars: | 2023-03-01 | by ( Maggie Fick | ) www.reuters.com time to read: +3 min

[1/2] The European Ombudsman Emily O'Reilly speaks during an interview with Reuters in Brussels, Belgium February 28, 2023. The Commission said in June 2022 that it no longer had the texts, which later drew criticism from the EU ombudsman. O’Reilly argued many people would understand why von der Leyen approached Bourla to plead Europe’s case for vaccines, as tens of thousands of people on the continent were dying from COVID-19. It has proposed to other EU institutions that they do the same, the spokesperson added. In February, the New York Times said it was suing the Commission over failure to release the text messages.

☆ Exclusive: EU may pay more for Pfizer COVID shots in return for lower volume
▼ + stars: | 2023-01-27 | by ( Maggie Fick | ) www.reuters.com time to read: +5 min

A Pfizer spokesperson declined to comment on details of the discussions, but said the company has shown ongoing commitment to accommodating EU member state concerns. Most people in the EU who wanted a primary course of the COVID-19 vaccine, and those who were later eligible for boosters, have received them. In May 2021, Brussels signed a contract with Pfizer and BioNTech to buy 900 million doses, with an option for an additional 900 million doses, by the end of 2023. Around half or more of the first 900 million doses from that contract have not yet been delivered because demand dropped last year. That came after EU governments warned Pfizer and other companies that millions of doses could go to waste.

☆ A Chinese bank is offering customers a Pfizer COVID-19 vaccine if they deposit $500,000 into an account
▼ + stars: | 2023-01-10 | by ( Britney Nguyen | ) www.businessinsider.com time to read: +2 min

A Chinese state-owned bank in Hong Kong is offering a Pfizer shot to customers who deposit about $500,000. The incentive signals mainland Chinese citizens' desire to receive a western developed mRNA vaccine. The "privileges" are being offered after mainland China lifted travel restrictions to Hong Kong. BioNTech's Pfizer mRNA vaccine is not widely available in mainland China, which has mostly relied on Chinese-produced vaccines that don't currently include mRNA technology. However, permanent residents of Hong Kong and Macau have had access to free Pfizer vaccines, according to Fortune.

[1/2] Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany. In its lawsuit, Moderna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March. Pfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and arguing its patents "far exceed its actual contributions to the field."

☆ New hope China may soften on Covid boosts our stocks most tied to world's No. 2 economy
▼ + stars: | 2022-11-04 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

After all, Chinese officials have not announced an official transition away from their very strict Covid policy. Nevertheless, the moves in certain stocks tied to China — including many owned by the Club — show the market is taking the vaccine policy change in stride. The cosmetics giant has a big China business and just a few days ago it cut its sales guidance partly due to China's Covid policy. The price move provided some support for oil stocks in Friday's volatile stock market. It's not immediately clear when expatriates in China could actually start getting a shot of the BioNTech-Pfizer Covid vaccine.

☆ Pfizer releases more data indicating omicron boosters are better than old Covid shots
▼ + stars: | 2022-11-04 | by ( Spencer Kimball | ) www.cnbc.com time to read: +4 min

Pfizer and BioNTech also found that people with and without prior Covid infections had a significant increase in their antibody levels after the omicron boosters. Pfizer and BioNTech released more human data Friday indicating the omicron BA.5 boosters perform better than the old Covid shots. Pfizer and BioNTech released the first human data in October showing the omicron boosters trigger a better immune response. They found the new boosters and the old shots performed about the same against omicron BA.5. The scientific community and public health officials are closely following data on the boosters because the FDA authorized them without direct human data.

☆ Pfizer COVID vaccine price hike seen giving revenue boost for years
▼ + stars: | 2022-10-21 | by ( Michael Erman | ) www.reuters.com time to read: +2 min

Oct 21 (Reuters) - Pfizer's plan to as much as quadruple current U.S. prices for its COVID-19 vaccines going forward could spur revenue for years, analysts said. Outside the United States, Pfizer said it already has contracts with governments in many developed markets that extend through 2023 with prices that have already been set. Moderna had previously suggested commercial price expectations in a range of $64 to $100 a shot. Wall Street was expecting such price hikes due to weak demand for COVID vaccines, which meant manufacturers would need to hike prices to meet revenue forecasts for 2023 and beyond. Around 19.4 million people in the United States received the updated booster over the first seven weeks of its rollout.

☆ Fact Check-Preventing transmission never required for COVID vaccines’ initial approval; Pfizer vax did reduce transmission of early variants
▼ + stars: | 2022-10-14 | by ( Reuters Fact Check | ) www.reuters.com time to read: +11 min

To get emergency approval, companies needed to show that the vaccines were safe and prevented vaccinated people from getting ill. They did not have to show that the vaccine would also prevent people from spreading the virus to others. Pfizer ‘vaccine’ wasn’t intended to prevent transmission. The newest family of Omicron variants has further eroded vaccine effectiveness against infection and transmission (here) . But even Omicron does not escape vaccine protection completely.

☆ U.S. cutting global donations of Pfizer COVID shots as demand slows
▼ + stars: | 2022-09-22 | by ( Michael Erman | ) www.reuters.com time to read: +2 min

REUTERS/Rodrigo GarridoNEW YORK, Sept 22 (Reuters) - The United States is significantly cutting back the number of Pfizer (PFE.N)/BioNTech (22UAy.DE) COVID-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries. The United States will have an option to buy up to an additional 400 million shots for the program after this year. Pfizer said it had already delivered 400 million vaccine doses in 79 countries under the U.S. government contract. The vaccine doses were donated through the COVAX program, run by the World Health Organization and GAVI global vaccine alliance, which was intended to deliver COVID-19 shots to the world's poorer countries. COVAX has been negotiating since june with vaccine manufacturers to cut or slow deliveries of 400 million to 600 million vaccine doses from its own contracts.

☆ Fact Check-Vaccine-effectiveness study does not show ‘negative immunity’ or harm to the immune system
▼ + stars: | 2022-09-19 | by ( Reuters Fact Check | ) www.reuters.com time to read: +7 min

“The statement that ‘the vaccine destroys any protection a person has from natural immunity’ is unfounded,” Lin told Reuters in an email. The combination of prior infection with vaccination offered slightly better protection than vaccination alone or infection alone, the study also showed. Two of four curves (lines) in panel A, representing vaccine effectiveness among children who received their shots in late 2021, continue a downward path past the bottom of the graph. Similarly, in panel B, lines depicting waning vaccine effectiveness over time in previously-infected and -uninfected children continue past the bottom of the graph. “Our study shows that the vaccine was effective against infection for 4 months, although the effectiveness waned over time,” Lin explained.

☆ Три случая смерти в Румынии после вакцинации Pfizer
▼ + stars: | 2021-03-23 | by ( Mld Media Srl | ) noi.md time to read: +2 min

Указанная прямая причина смерти - тяжелая сердечно-дыхательная недостаточность и патологические состояния - полиорганная дисфункция и бронхопневмония с sars-cov 2. Логичный вопрос: развивалась ли эта тяжелая сердечная недостаточность и бронхопневмония взрывным образом после вакцинации - или она была вакцинирована безответственно, когда у нее уже проявлялись симптомы болезни? Тот же вопрос можно задать и в случае мужчины - ему был 71 год, он умер от тяжелой сердечной недостаточности, ишемической болезни сердца и гипертонии. Сын покойных рассказал: «До вакцинации они чувствовали себя плохо, так как оба были простуженными. - примерно через 48 часов «после иммунизации второй дозой вакцины Pfizer COVID-19», сообщают Antena 3 и RTV.

Persons: Дулгеру Locations: ФилипештийдеПэдуре, Прахов, Кымпина, Васлуй

☆ VIDEO/ Președintele ales al SUA, Joe Biden, s-a vaccinat împotriva COVID-19, în direct la TV
▼ + stars: | 2020-12-22 | by ( ) www.zdg.md time to read: +1 min

Președintele ales, Joe Biden, a primit prima doză de vaccin Pfizer Covid-19, spunând că a acceptat ca procedura să fie filmată și transmisă în direct pentru a le arăta americanilor că este „sigur de luat” vaccinul, transmite BBC. Joe Biden se alătură unui număr din ce în ce mai mare de lideri politici care acceptă să fie vaccinate în public, inclusiv vicepreședintele Mike Pence și președintele Camerei Nancy Pelosi. „Fac asta pentru a demonstra că oamenii ar trebui să fie pregătiți pentru a se vaccina, atunci când este disponibil acesta. Nu e nimic de îngrijorător”, a spus Biden, fiind la Newark, Delaware, acolo unde a fost vaccinat în direct la televizor. Și soția lui Biden, Jill Biden, s-a vaccinat tot în aceeași zi, a declarat președintele ales.

Persons: Joe Biden, Mike, Camerei Nancy Pelosi, Biden, Jill Biden, Harris, Doug Emhoff Organizations: BBC, Camerei Locations: Newark, Delaware

Search resuls for: "Pfizer COVID"

23 mentions found